2021
DOI: 10.1148/radiol.2021203959
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative Analysis of Adipose Depots by Using Chest CT and Associations with All-Cause Mortality in Chronic Obstructive Pulmonary Disease: Longitudinal Analysis from MESArthritis Ancillary Study

Abstract: Excessive adipose depots and sarcopenia are associated with poor prognosis and mortality in several chronic conditions including chronic obstructive pulmonary disease (COPD) (1,2). Obesity is associated with lower mortality in patients with COPD, referred to as the obesity paradox (3). Sarcopenia is the clinical syndrome of diminished muscle mass and strength and has an estimated prevalence of 22% in patients with COPD (2,4). In contradistinction to obesity, sarcopenia is associated with higher risks of mortal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
40
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 30 publications
(43 citation statements)
references
References 35 publications
3
40
0
Order By: Relevance
“…Between April 2010 and January 2012 (fifth MESA exam), 3,137 participants in the MESA consented to participate in the MESA Lung Ancillary Study and underwent chest CT exams [ 19 ]. The MESArthritis Ancillary Study is an analysis of the available CT exams of 3,083 of these participants [ 20 ]. It is aimed to investigate the roles of CT-derived soft tissue and bone biomarkers associated with incidence and clinical outcomes of several cardiometabolic and cardiopulmonary diseases.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Between April 2010 and January 2012 (fifth MESA exam), 3,137 participants in the MESA consented to participate in the MESA Lung Ancillary Study and underwent chest CT exams [ 19 ]. The MESArthritis Ancillary Study is an analysis of the available CT exams of 3,083 of these participants [ 20 ]. It is aimed to investigate the roles of CT-derived soft tissue and bone biomarkers associated with incidence and clinical outcomes of several cardiometabolic and cardiopulmonary diseases.…”
Section: Methodsmentioning
confidence: 99%
“…The non-contrast–enhanced chest CT exams (acquired at suspended full inspiration using 64-slice multidetector row CT scanners, Siemens Medical Solutions, Erlangen, Germany or GE Healthcare, Waukesha, Wisconsin, USA) were used to measure the IMAT and SAT areas as well as the pectoralis muscles (PMs) density [ 19 , 23 ]. The cross-sectional SAT area was measured as the area between the PM and skin surface in the slice just above the superior margin of the aortic arch [ 20 , 24 ]. Density of the SAT area was analyzed to estimate an individualized attenuation threshold for the IMAT (i.e., the extramyocellular lipid content) [ 20 , 25 ].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The details of the MESA study design have been published previously ( 24 ). The MESArthritis study is an ancillary retrospective study of the MESA cohort to investigate the association of CT-derived soft tissue biomarkers with cardiovascular and metabolic risk factors and clinical outcomes ( 25 ). Previous reports of the MESArthritis study used the whole-chest CT scans of the MESA participants in exam 5; however, we have used the cardiac CT scans for our analysis ( 25 ).…”
Section: Methodsmentioning
confidence: 99%
“…The MESArthritis study is an ancillary retrospective study of the MESA cohort to investigate the association of CT-derived soft tissue biomarkers with cardiovascular and metabolic risk factors and clinical outcomes (25). Previous reports of the MESArthritis study used the whole-chest CT scans of the MESA participants in exam 5; however, we have used the cardiac CT scans for our analysis (25). Available non-contrast cardiac CT images from 3,305 participants acquired in the 5 th Institutional review boards at each of the six field centers recruited in the MESA study approved the study protocol.…”
Section: Participant Selectionmentioning
confidence: 99%